Return to home page
Searching: Otterbein library catalog
We are currently experiencing delivery delays for items requested from other institutions while transitioning to a new statewide delivery service. Please contact your library with questions or advice about alternative resources. Thank you for your patience!
  Previous Record Previous Item Next Item Next Record
  Reviews, Summaries, etc...
EBOOK
Title Neuroendocrine neoplasia management : new approaches for diagnosis and treatment / Giordano Beretta, Alfredo Berruti, Emilio Bombardieri, Nicola Fazio, Orlando Goletti, editors.
Imprint Cham : Springer, [2021]
2021

LOCATION CALL # STATUS MESSAGE
 OHIOLINK SPRINGER EBOOKS    ONLINE  
View online
LOCATION CALL # STATUS MESSAGE
 OHIOLINK SPRINGER EBOOKS    ONLINE  
View online
Subject Neuroendocrine tumors -- Diagnosis.
Neuroendocrine tumors -- Treatment.
Alt Name Beretta, Giordano,
Berruti, Alfredo,
Bombardieri, E. (Emilio),
Fazio, Nicola,
Goletti, Orlando,
Description 1 online resource (xiv, 331 pages) : illustrations (chiefly color)
Bibliography Note Includes bibliographic references.
Summary "This book provides the most recent update on the management of neuroendocrine neoplasia (NEN), a term covering all tumors of various organs and/or with a particular histology, including MEN (multiple endocrine neoplasia) related tumors, MiNEN (mixed neuroendocrine-non-neuroendocrine neoplasms), NEC (neuroendocrine carcinoma) and Merkel's carcinoma. NENs are heterogeneous in their biology, clinical presentation and prognosis, showing a great variability in aggressiveness and therapy response. As a result, their treatment is based on a large spectrum of options. The standard therapies are surgery in early disease, various loco-regional procedures in certain conditions and mostly of a palliative nature in metastatic disease. At present, thanks to our increased understanding of molecular signaling pathways, several pharmacological approaches can be used in patients with advanced NENs. Somatostatin analogs display both anti-tumor effects and symptom control. Novel peptide-radio-receptor treatment (PRRT) is used in patients with well differentiated tumors. The agents targeting angiogenesis and/or PI3K/AKT/mTOR pathway, alone or in combination with analogues, have provided encouraging results in advanced disease. The first part of the book focuses on the history, epidemiology and the most relevant scientific achievements, covering the discoveries in genetic and molecular biology, the endoscopic techniques with guided biopsy, and the metabolic imaging with hybrid PET/CT and MRI/CT. It particularly highlights the emerging strategies in therapy, surgery and mini-invasive surgery as well as loco-regional and systemic treatments, including targeted therapy and/or biological therapies. The second part then explores the management of NENs of various anatomical origins and/or with peculiar biology. It describes the range of the current options and the most relevant results from the clinical trials. This informative book provides valuable insights for all those interested in the management of neuroendocrine neoplasia."--Publisher's description.
Contents Part-1: General. History of Neuroendocrine Neoplasia -- Epidemiology of neuroendocrine neoplasms. Part-2: Diagnosis. New concepts in patholog -- Molecular Biology of Neuroendocrine Tumors -- Circulating biochemical markers of gastro-entero-pancreatic (GEP) neuroendocrine neoplasms (NENs) -- Advances in diagnostic imaging. Part-3: New Approaches for Treatment. Treatment of NET related symptoms -- New Surgical Strategies -- New approaches in medical therapies -- Loco-regional Therapies of NEN -- Radioreceptor therapy -- NETs of the lung -- Part-4: Treatment of NETs From Different Organ Origin. Gastric Neuroendocrine Tumors -- Treatment of Pancreatic Neurendocrine Tumors -- Treatment of intestinal NETs (including appendix) -- Treatment of NETs from rare origin -- Neuroendocrine Neoplasms with Peculiar Biology and Features: MEN1, MEN2A, MEN2B, MEN4, VHL, NF1. Part-5: NETs with Peculiar Biology and Feature. Mixed Neuroendocrine and Non-Neuroendocrine Neoplasms ( Mi NEN) -- Merkel Cell Carcinoma -- Therapy in poorly differentiated neuroendocrine neoplasms (NEN G3) -- Conclusion:NENs management today looking at the future.
Note Online resource; title from PDF title page (SpringerLink, viewed August 3, 2021).
ISBN 9783030728304 (electronic bk.)
3030728307 (electronic bk.)
9783030728298 (print)
3030728293 (print)
ISBN/ISSN 10.1007/978-3-030-72830-4
OCLC # 1260821101
Additional Format Print version : 9783030728298 (OCoLC)1264031612
Original 3030728293 9783030728298 (OCoLC)1240492872



If you experience difficulty accessing or navigating this content, please contact the OPAL Support Team